Latest Breaking News On - Eyepoint pharmaceuticals - Page 1 : comparemela.com

Monashee Investment Management LLC Takes $4 04 Million Position in EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT)

Monashee Investment Management LLC bought a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 175,000 shares of the company’s stock, valued at approximately $4,044,000. EyePoint Pharmaceuticals accounts for about 0.7% of Monashee […]

Robertw bairdDavidr guyerSecurities exchange commissionQuarter for eyepoint pharmaceuticalsInvestment advisersDeutsche bankEyepoint pharmaceuticals company profileChina universal asset management coEyepoint pharmaceuticalsEyepoint pharmaceuticals incMirae asset global investments coNews ratings for eyepoint pharmaceuticals dailyMonashee investment managementEyepoint pharmaceuticals stock performanceToth financial advisory corpInsider activity at eyepoint pharmaceuticals

ARVO 2024: Possible link between long COVID, vision changes tops Healio s written items

ARVO 2024: Possible link between long COVID, vision changes tops Healio s written items
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Association for researchEyepoint pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $11 16

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $11.16, but opened at $10.90. EyePoint Pharmaceuticals shares last traded at $11.13, with a volume of 79,034 shares. Analyst Ratings Changes Several research analysts have recently issued reports on the company. […]

Davidr guyerRobertw bairdInstitutional trading of eyepoint pharmaceuticalsSecurities exchange commissionEyepoint pharmaceuticals incEyepoint pharmaceuticals company profileMirae asset global investments coEyepoint pharmaceuticals stockNews ratings for eyepoint pharmaceuticals dailyDeutsche bankInvestment advisersEyepoint pharmaceuticalsTower research capitalAmeritas investment partners incGet free reportPoint pharmaceuticals

Uveitis Treatment Market and Competitive Landscape Report,

Dublin, May 16, 2024 (GLOBE NEWSWIRE) The

United statesAsia pacificAlimera sciencesBausch healthEyepoint pharmaceuticalsDrug stores retail pharmaciesList of uveitis treatment companiesPorter fiveTreatment market reportCompetitive analysisTreatment marketDrug classDisease typeDistribution channelUveitis treatmentSize estimates

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMacau generalHong kongAmy phillipsChristina tartagliaEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsEquinox sciencesEyepoint pharmaceuticals incGreen room communicationsBetta pharmaceuticalsCompensation committeePoint pharmaceuticalsTerm incentive planEyepoint pharmaceuticalIhr portfolio